The Effectiveness and Safety of Direct-Acting Antivirals in the Treatment of Hepatitis C Virus in Saudi Arabia: A Nationwide Study Based on the Saudi Ministry of Health Surveillance Data From 2017 to 2021

Background and objective While the Kingdom of Saudi Arabia (KSA) has had a hepatitis C virus (HCV) elimination program in place since 2015, there have been limited studies investigating the effectiveness and safety of direct-acting antivirals (DAAS) based on the Ministry of Health (MOH) surveillance...

Descripción completa

Detalles Bibliográficos
Autores principales: AL-Ahmari, Tasneem S., Alotaibi, Adel F, Aljasser, Areej I, Aljasser, Abdulrahman I, Eldaw, Anwar M, Abd-Ellatif, Eman E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469617/
https://www.ncbi.nlm.nih.gov/pubmed/37664260
http://dx.doi.org/10.7759/cureus.42780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469617/
https://www.ncbi.nlm.nih.gov/pubmed/37664260
http://dx.doi.org/10.7759/cureus.42780

Ejemplares similares